These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 31516914)
1. Blood neurofilament light chain at the doorstep of clinical application. Leppert D; Kuhle J Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e599. PubMed ID: 31516914 [No Abstract] [Full Text] [Related]
2. Reference values for plasma neurofilament light chain in healthy Chinese children. Jin J; Cui Y; Hong Y; Zhou D; He N; Mao Z; Mao S Clin Chem Lab Med; 2022 Jan; 60(1):e10-e12. PubMed ID: 34449172 [No Abstract] [Full Text] [Related]
3. Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain. Abdelhak A; Kuhle J; Green AJ JAMA Neurol; 2023 Jun; 80(6):542-543. PubMed ID: 37010852 [TBL] [Abstract][Full Text] [Related]
4. Reference values for plasma neurofilament light chain (NfL) in healthy Chinese. Chen J; Yang X; Zhang Y; Zheng P; Wei C; Mao Z; He W; Jin WN Clin Chem Lab Med; 2021 Mar; 59(4):e153-e156. PubMed ID: 33068379 [No Abstract] [Full Text] [Related]
5. Serum neurofilament light chain studies in neurological disorders, hints for interpretation. Mariotto S; Sechi E; Ferrari S J Neurol Sci; 2020 Sep; 416():116986. PubMed ID: 32563076 [No Abstract] [Full Text] [Related]
6. Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy. Beerepoot S; Heijst H; Roos B; Wamelink MMC; Boelens JJ; Lindemans CA; van Hasselt PM; Jacobs EH; van der Knaap MS; Teunissen CE; Wolf NI Brain; 2022 Mar; 145(1):105-118. PubMed ID: 34398223 [TBL] [Abstract][Full Text] [Related]
7. Neurofilament light chain levels in MS: At the doorstep of clinical application. Dalmau J Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):. PubMed ID: 31454779 [No Abstract] [Full Text] [Related]
8. Neurofilament makes light of MS treatment monitoring. Fyfe I Nat Rev Neurol; 2019 Apr; 15(4):188. PubMed ID: 30804512 [No Abstract] [Full Text] [Related]
9. The multifaceted role of neurofilament light chain protein: emerging opportunities in primary psychiatric conditions. Bavato F; Seifritz E; Quednow BB Brain; 2024 Jan; 147(1):e5-e6. PubMed ID: 37615305 [No Abstract] [Full Text] [Related]
10. Serum neurofilament light chain level as a biomarker of neurodegeneration and predictor of white-matter abnormality progression. Murthy JK; Das S Eur J Neurol; 2020 Oct; 27(10):e55. PubMed ID: 32526090 [No Abstract] [Full Text] [Related]
11. Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis. Brune-Ingebretsen S; Høgestøl EA; de Rosbo NK; Berg-Hansen P; Brunborg C; Blennow K; Zetterberg H; Paul F; Uccelli A; Villoslada P; Harbo HF; Berge T J Neuroimmunol; 2023 Sep; 382():578175. PubMed ID: 37573634 [TBL] [Abstract][Full Text] [Related]
12. Association of admission serum levels of neurofilament light chain and in-hospital mortality in geriatric patients with COVID-19. Marchegiani F; Recchioni R; Marcheselli F; Di Rosa M; Sabbatinelli J; Matacchione G; Giuliani A; Ramini D; Stripoli P; Biscetti L; Pelliccioni G; Sarzani R; Spannella F; Cherubini A; Corsonello A; Procopio AD; Bonfigli AR; Bonafè M; Lattanzio F; Olivieri F J Neurol; 2023 Jan; 270(1):37-43. PubMed ID: 36114298 [No Abstract] [Full Text] [Related]
13. Serum neurofilament light chain as a preclinical marker of neurodegeneration. Parnetti L; Gaetani L; Di Filippo M Lancet Neurol; 2019 Dec; 18(12):1070-1071. PubMed ID: 31701888 [No Abstract] [Full Text] [Related]
14. Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis. Berger T; Stüve O Neurology; 2019 Mar; 92(10):451-452. PubMed ID: 30737335 [No Abstract] [Full Text] [Related]
15. Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity. Ineichen BV; Moridi T; Ewing E; Ouellette R; Manouchehrinia A; Stawiarz L; Ferreira D; Muehlboeck SJ; Kuhle J; Westman E; Leppert D; Hillert J; Olsson T; Kockum I; Piehl F; Granberg T J Intern Med; 2021 Aug; 290(2):473-476. PubMed ID: 33871105 [No Abstract] [Full Text] [Related]
16. Neurofilament Light Chain as a Biomarker in Cerebral Small-Vessel Disease. Peters N Mol Diagn Ther; 2022 Jan; 26(1):1-6. PubMed ID: 34825310 [TBL] [Abstract][Full Text] [Related]
17. Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease. Brier MR; Day GS Brain; 2020 Dec; 143(12):3521-3522. PubMed ID: 33253358 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of neurofilament light chain in natalizumab therapy for different phases of multiple sclerosis: A systematic review and meta-analysis. Liu N; Sun M; Zhang W; Sun J; Gong P; Wang H; Wang M J Clin Neurosci; 2022 Jul; 101():198-203. PubMed ID: 35617924 [TBL] [Abstract][Full Text] [Related]